MedPage Today on MSN
FDA Panel Gives Thumbs Down to Novel Strategy for Switching Breast Cancer Therapy
Panelists conflicted about positive trial's ability to validate biomarker-guided switching ...
The FDA’s Oncologic Drugs Advisory Committee (ODAC) on Thursday voted 6 to 3 that AstraZeneca has not demonstrated its oral ...
The British pharmaceutical group said it would continue to work with U.S. regulators on a review of its breast-cancer ...
Members of the FDA’s Oncologic Drugs Advisory Committee questioned AstraZeneca’s trial design of switching treatments earlier ...
Stocktwits on MSN
AZN Stock Rise As Wall Street Dismisses FDA Committee’s Rejection Of Breast Cancer Drug
Jefferies analyst Michael Leuchten maintained a ‘Buy’ rating and $243 price target on AstraZeneca following the committee vote on camizestrant. ・This suggests that the FDA is now unlikely to approve ...
MedPage Today on MSN
FDA Staff Raises Concerns on Two Cancer Drug Applications
The Oncologic Drugs Advisory Committee will meet for the first time in 9 months ...
SPRINGFIELD, Mass. (WWLP) – Springfield’s Health and Human Services Committee convened to address disparities in cancer testing and care, focusing on the higher breast cancer mortality rate among ...
Rep. Brandei Schaefbauer, R-Aberdeen, listens to a presentation on the House State Affairs Committee on Jan. 22, 2025. (Makenzie Huber/South Dakota Searchlight) A bill intended to eliminate ...
INDIANAPOLIS (WISH) — The Komen Tissue Bank at the IU Simon Comprehensive Cancer Center is partnering with the WNBA All-Star Committee for a historic breast tissue collection event from July 12-13 to ...
Springfield committee addresses breast cancer disparities Springfield's Health and Human Services Committee convened to address disparities in cancer testing and care, focusing on the higher breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results